About: The clinical utility and limitations of serum carbohydrate antigen (CA19-9) as a diagnostic tool for pancreatic cancer and cholangiocarcinoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The clinical utility and limitations of serum carbohydrate antigen (CA19-9) as a diagnostic tool for pancreatic cancer and cholangiocarcinoma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 23 April 2011

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) наукова стаття, опублікована у квітні 2011 (uk) مقالة علمية نشرت في 23 أبريل 2011 (ar) scientific article published on 23 April 2011 (en) artículu científicu espublizáu n'abril de 2011 (ast)
publication date	wds:Q37868446-CA5CCE40-BC2A-4E2E-B4AF-067BA495A51E
publication date	2011-04-23 00:00:00Z (xsd:dateTime)
exact match	wds:Q37868446-BC2DFE42-EA03-4F73-888B-659DA5F4BE7E
exact match	https://scigraph.springernature.com/pub.10.1007/s10620-011-1709-8
cites work	wds:Q37868446-158CFA88-C601-4C3C-8742-5EBB14BF1967 wds:Q37868446-17E92CEB-C571-4B2E-B2F3-385782EC9C43 wds:Q37868446-34D65A5C-BD3A-4A5A-AD8A-C507A3F4541A wds:Q37868446-492D44E5-96D8-4BD5-BDE7-905F3B5B851F wds:Q37868446-5B68C5E0-0A7C-4406-9558-37FFC48A0D5A wds:Q37868446-7EE0310C-10F9-457F-B150-DB33D7961D92 wds:Q37868446-8F9D9430-F8DE-485A-B53A-E1032B2EA5A4 wds:Q37868446-9F99F43F-F026-4F6D-AFAD-8766AAE7C578 wds:Q37868446-A0AA4359-F6D9-4BA7-B3D8-D627B868451E wds:Q37868446-E9AB6A2F-26B4-430F-A6CA-BBBD66F898BC wds:Q37868446-FB005DD0-15C2-46D5-80A3-804F40C58A28
cites work	Colorectal carcinoma antigens detected by hybridoma antibodies Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer. EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma Type 2 diabetes mellitus and CA 19-9 levels The clinical utility of the CA 19-9 tumor-associated antigen. Prospective Evaluation of the Diagnostic Efficacy of CA 19–9 Assay as a Marker for Gastrointestinal Cancers New carbohydrate tumor markers Endoscopic ultrasound in the evaluation of radiologic abnormalities of the liver and biliary tree Efficacy of endoscopic ultrasound in characterizing mass lesions in chronic pancreatitis
author name string	wds:Q37868446-0477E5B8-F12A-4B59-B314-C194868ED96A wds:Q37868446-4A7595CE-357D-42D2-9802-FAC5A91ECD06 wds:Q37868446-841AD19F-D14A-4D16-9891-F5FBAE4249F5 wds:Q37868446-9359DD1A-597D-4C8C-996E-DA40E5558360 wds:Q37868446-F9466EB2-E6A8-477F-B57B-6AC6FC32D574
author name string	Shou-jiang Tang Luis F Lara Ali Siddiqui Sundeep Singh Jayaprakash Sreenarasimhaiah
rdfs:label	The clinical utility and limitations of serum carbohydrate antigen (nl) The clinical utility and limitations of serum carbohydrate antigen (CA19-9) as a diagnostic tool for pancreatic cancer and cholangiocarcinoma (en)
skos:prefLabel	The clinical utility and limitations of serum carbohydrate antigen (nl) The clinical utility and limitations of serum carbohydrate antigen (CA19-9) as a diagnostic tool for pancreatic cancer and cholangiocarcinoma (en)
name	The clinical utility and limitations of serum carbohydrate antigen (nl) The clinical utility and limitations of serum carbohydrate antigen (CA19-9) as a diagnostic tool for pancreatic cancer and cholangiocarcinoma (en)
title	wds:Q37868446-9F021E3F-245C-449F-855C-2BD561568265
title	The clinical utility and limitations of serum carbohydrate antigen (CA19-9) as a diagnostic tool for pancreatic cancer and cholangiocarcinoma (en)
page(s)	wds:Q37868446-83B48486-8BA4-4C47-81C7-CD4EDBB0EF74
page(s)	2491-2496
instance of	wds:Q37868446-4905239C-E3D4-4A67-AA19-A20695A1B471
instance of	scholarly article
main subject	wds:Q37868446-66ECDC7B-C438-4421-B79F-D9A144CA98D7 wds:Q37868446-80D5E485-4A78-493E-84B0-24684F523411 wds:Q37868446-975e205c-1ffa-43b1-837b-ac291172ea3f
main subject	pancreatic cancer Diagnosis cholangiocarcinoma
PubMed ID	wds:Q37868446-1986EE9C-0F15-45B1-A699-FE7635F5994B
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21516323
PubMed ID	21516323
published in	wds:Q37868446-ACE507D9-741A-432B-A257-73D19DAEA28E
published in	Digestive Diseases and Sciences
issue	wds:Q37868446-817E4E39-B29C-4819-AFBE-8C80792E222B
volume	wds:Q37868446-D80F5D45-7B26-4DE3-95F0-78EE5C3EE059
issue	8
volume	56
DOI	wds:Q37868446-FF4E58FD-03BD-42F4-B04F-45AE4F1BE4D9
DOI	http://dx.doi.org/10.1007/S10620-011-1709-8
DOI	10.1007/S10620-011-1709-8
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q37868446
is cites work of	Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier Biomarkers for early diagnosis of pancreatic cancer Metabolic system alterations in pancreatic cancer patient serum: potential for early detection Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients Elevated preoperative serum CA19-9 levels in patients with hepatocellular carcinoma is associated with poor prognosis after resection. iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance PAM4 enzyme immunoassay alone and in combination with CA 19-9 for the detection of pancreatic adenocarcinoma Metabonomic changes from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma in tissues from rats Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues Programmed cell death 6 interacting protein (PDCD6IP) and Rabenosyn-5 (ZFYVE20) are potential urinary biomarkers for upper gastrointestinal cancer. ENO1 Overexpression in Pancreatic Cancer Patients and Its Clinical and Diagnostic Significance. The prognostic potential and oncogenic effects of PRR11 expression in hilar cholangiocarcinoma Clinical significance of serum COL6A3 in pancreatic ductal adenocarcinoma.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software